Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids
- 1 July 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 145 (6), 767-774
- https://doi.org/10.1038/sj.bjp.0706245
Abstract
Excess triglyceride (TG) accumulation and increased fatty acid (FA) oxidation in the diabetic heart contribute to cardiac dysfunction. Punica granatum flower (PGF) is a traditional antidiabetic medicine. Here, we investigated the effects and mechanisms of action of PGF extract on abnormal cardiac lipid metabolism both in vivo and in vitro. Long-term oral administration of PGF extract (500 mg kg(-1)) reduced cardiac TG content, accompanied by a decrease in plasma levels of TG and total cholesterol in Zucker diabetic fatty (ZDF) rats, indicating improvement by PGF extract of abnormal cardiac TG accumulation and hyperlipidemia in this diabetic model. Treatment of ZDF rats with PGF extract lowered plasma FA levels. Furthermore, the treatment suppressed cardiac overexpression of mRNAs encoding for FA transport protein, peroxisome proliferator-activated receptor (PPAR)-alpha, carnitine palmitoyltransferase-1, acyl-CoA oxidase and 5'-AMP-activated protein kinase alpha2, and restored downregulated cardiac acetyl-CoA carboxylase mRNA expression in ZDF rats, whereas it showed little effect in Zucker lean rats. The results suggest that PGF extract inhibits increased cardiac FA uptake and oxidation in the diabetic condition. PGF extract and its component oleanolic acid enhanced PPAR-alpha luciferase reporter gene activity in human embryonic kidney 293 cells, and this effect was completely suppressed by a selective PPAR-alpha antagonist MK-886, consistent with the presence of PPAR-alpha activator activity in the extract and this component. Our findings suggest that PGF extract improves abnormal cardiac lipid metabolism in ZDF rats by activating PPAR-alpha and thereby lowering circulating lipid and inhibiting its cardiac uptake.Keywords
This publication has 40 references indexed in Scilit:
- Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Anti-diabetic action of flower extract: Activation of PPAR-γ and identification of an active componentToxicology and Applied Pharmacology, 2005
- Prediction of PPAR-α ligand-mediated physiological changes using gene expression profilesJournal of Lipid Research, 2004
- A Natural Product Ligand of the Oxysterol Receptor, Liver X ReceptorJournal of Pharmacology and Experimental Therapeutics, 2003
- A novel mechanism for the inhibition of NFκB activation in vascular endothelial cells by natural antioxidantsThe FASEB Journal, 2002
- Overexpression of Apolipoprotein B in the Heart Impedes Cardiac Triglyceride Accumulation and Development of Cardiac Dysfunction in Diabetic MiceJournal of Biological Chemistry, 2002
- Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886Biochemical Journal, 2001
- Regulation of energy substrate metabolism in the diabetic heartCardiovascular Research, 1997
- Expression cloning and characterization of a novel adipocyte long chain fatty acid transport proteinCell, 1994
- Anti-Inflammatory Activity of Gallic AcidPlanta Medica, 1992